INCB053914

Overview

INCB053914 is a pan-PIM inhibitor that can work by blocking specific chemicals in the cancer cell that block some cells from dividing and growing.

SparkCures ID 228
Developed By Incyte Corporation
Generic Name INCB053914
Treatment Classifications
  • Pan-PIM Protein Kinase Inhibitor

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.